lisocabtagene maraleucel,,Cyclophosphamide,Fludarabine
BMS
['lisocabtagene', 'mantle,(-dismantle)', 'breyanzi', 'transcend,(-nhl-001),(-nhl 001),(-nhl001),(-nhl-006),(-nhl 006),(-nhl006),(-pilot-017006),(-pilot017006),(-pilot 017006)', 'lymphoma', 'follicular', 'bristol', '$bmy']
$bmy bristol myers squibb's breyanzi (lisocabtagene maraleucel) delivers deep and durable responses in relapsed or refractory follicular lymphoma and mantle cell lymphoma in transcend clinical trials presented at icml 2023
Options trader. Market-news. Nothing posted constitutes as advice. Do your own diligence.